71 related articles for article (PubMed ID: 23961491)
1. Efficacy and safety of pioglitazone in type 2 diabetes in the Indian patients: Results of an observational study.
Balaji V
Indian J Endocrinol Metab; 2013 Jul; 17(4):709-15. PubMed ID: 23961491
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of a Fixed-Dose Combination of Vildagliptin and Pioglitazone in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Comparative, Phase III Study.
Erande S; Mukhopadhyay J; Dange A; Deogaonkar A; Birla A; Doshi C; Revankar S; B SS; Kumar N; Kadam PV
Cureus; 2023 Sep; 15(9):e44548. PubMed ID: 37795066
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of pioglitazone in type 2 diabetes mellitus: a postmarketing observational study.
Nafrialdi
Acta Med Indones; 2012 Jan; 44(1):28-34. PubMed ID: 22451182
[TBL] [Abstract][Full Text] [Related]
4. Acarbose improves glycemic control as add-on or monotherapy in Indian type-2 diabetes: Findings from the GlucoVIP multinational observational study.
Philip E; Sundaram ML; Das R; Chauhan SK; Deshpande S; Ambhore S; Rathod R; Manjrekar P
Indian J Endocrinol Metab; 2013 Dec; 17(Suppl 3):S674-9. PubMed ID: 24910836
[TBL] [Abstract][Full Text] [Related]
5. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus.
Ved P; Shah S
Indian J Endocrinol Metab; 2012 Mar; 16 Suppl 1(Suppl1):S110-3. PubMed ID: 22701828
[TBL] [Abstract][Full Text] [Related]
7. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
[TBL] [Abstract][Full Text] [Related]
8. Comparison of effects of gliclazide, metformin and pioglitazone monotherapies on glycemic control and cardiovascular risk factors in patients with newly diagnosed uncontrolled type 2 diabetes mellitus.
Erem C; Ozbas HM; Nuhoglu I; Deger O; Civan N; Ersoz HO
Exp Clin Endocrinol Diabetes; 2014 May; 122(5):295-302. PubMed ID: 24710641
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
[TBL] [Abstract][Full Text] [Related]
10. Safety and effectiveness of insulin detemir in combination with oral antidiabetic agents in an outpatient specialist setting: results of the Italian SOLVE™ observational study.
Caputo S; Maran A; Mannino D; Morano S; Lastoria G; Nicoziani P
Minerva Endocrinol; 2015 Dec; 40(4):249-58. PubMed ID: 26551483
[TBL] [Abstract][Full Text] [Related]
11. Clinical Utility of a Digital Therapeutic Intervention in Indian Patients With Type 2 Diabetes Mellitus: 12-Week Prospective Single-Arm Intervention Study.
Chawla R; Jaggi S; Gupta A; Bantwal G; Patil S
JMIR Diabetes; 2022 Oct; 7(4):e41401. PubMed ID: 36226840
[TBL] [Abstract][Full Text] [Related]
12. Real-World Clinical Effectiveness and Tolerability of Hydroxychloroquine 400 Mg in Uncontrolled Type 2 Diabetes Subjects who are not Willing to Initiate Insulin Therapy (HYQ-Real-World Study).
Gupta A
Curr Diabetes Rev; 2019; 15(6):510-519. PubMed ID: 31713476
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.
Einhorn D; Rendell M; Rosenzweig J; Egan JW; Mathisen AL; Schneider RL
Clin Ther; 2000 Dec; 22(12):1395-409. PubMed ID: 11192132
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of type 2 diabetes mellitus patients of qi-yin deficiency phlegm-stasis inter-obstruction syndrome by jiangtang xiaozhi capsule and pioglitazone tablet: a non-inferiority randomized controlled trial].
Chen ZH; Xia CD; Wei ZX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Sep; 34(9):1042-6. PubMed ID: 25335325
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Combined Tofogliflozin and Glargine, Tofogliflozin Added to Insulin, and Insulin Dose-Increase Therapy in Uncontrolled Type 2 Diabetes.
Suzuki K; Mitsuma Y; Sato T; Anraku T; Hatta M
J Clin Med Res; 2016 Nov; 8(11):805-814. PubMed ID: 27738482
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of vildagliptin in clinical practice-results of the PROVIL-study.
Blüher M; Kurz I; Dannenmaier S; Dworak M
World J Diabetes; 2012 Sep; 3(9):161-9. PubMed ID: 23125906
[TBL] [Abstract][Full Text] [Related]
17. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of fixed dose combination of acarbose/metformin in Indian Type 2 diabetes patients: Results from observational GLOBE Study.
Saboo B; Reddy GC; Juneja S; Kedia AK; Manjrekar P; Rathod R;
Indian J Endocrinol Metab; 2015; 19(1):129-35. PubMed ID: 25593840
[TBL] [Abstract][Full Text] [Related]
19. Real-World Effectiveness and Safety of Lixisenatide as Add-On to Oral Antidiabetic Drugs as Part of Routine Clinical Practice in Bulgaria: LIXODAR Study.
Temelkova N; Vladeva S; Delchev A; Ivanova K; Gerasimova-Zheleva Y; Kuneva T; Pehlivanova V; Popivanov P
Diabetes Ther; 2019 Jun; 10(3):981-993. PubMed ID: 30919317
[TBL] [Abstract][Full Text] [Related]
20. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes.
Janka HU; Plewe G; Riddle MC; Kliebe-Frisch C; Schweitzer MA; Yki-Järvinen H
Diabetes Care; 2005 Feb; 28(2):254-9. PubMed ID: 15677775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]